| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/26/1993 | WO1993011431A1 Immunoassay using synthetic htlv-ii peptides |
| 05/26/1993 | EP0543425A1 Endothelin DNA and use thereof |
| 05/26/1993 | EP0543240A1 Polypeptide, DNA fragment encoding the same, drug composition containing the same and process for producing the same |
| 05/26/1993 | EP0543195A2 Biosynthetic process for the preparation of proteins |
| 05/26/1993 | EP0543076A2 Wheat alpha-amylase inhibitor for the treatment of diabetes |
| 05/26/1993 | EP0542998A1 Vaccine and treatment method of human immunodeficiency virus infection |
| 05/26/1993 | EP0542971A1 CLONING AND RECOMBINANT PRODUCTION OF RECEPTOR(S) OF THE ACTIVIN/TGF-$g(b) SUPERFAMILY |
| 05/26/1993 | EP0542970A1 Nucleotide and peptide sequences of an isolate of the hepatitis c virus, diagnostic and therapeutic applications thereof |
| 05/26/1993 | EP0542949A1 Hepatitis a virus strain, method for the isolation of said virus strains and hepatitis a vaccines |
| 05/26/1993 | EP0542937A1 Growth hormone releasing factor analogs |
| 05/26/1993 | EP0542934A1 Method of treating benign and malignant proliferative skin disease |
| 05/26/1993 | EP0542931A1 Serine protease variants having peptide ligase activity |
| 05/26/1993 | EP0542920A1 Cannabinoid receptor |
| 05/26/1993 | EP0542899A1 Peptides of the chromostatin family |
| 05/26/1993 | EP0542897A1 Producing monoclonal antibodies against human t-cell receptor elements using recombinant dna vectors. |
| 05/26/1993 | EP0542892A1 Chimeric neurotrophic factors |
| 05/26/1993 | EP0542887A1 Psoralen conjugated methylphosphonate oligonucleotides as therapeutic agents for chronic myelogenous leukemia |
| 05/26/1993 | EP0542863A1 Expression of recombinant polypeptides with improved purification |
| 05/26/1993 | EP0542843A1 Cloning and expression of toxoplasma antigens and use of recombinant antigens |
| 05/26/1993 | EP0542833A1 Insecticidal proteins |
| 05/26/1993 | EP0542830A1 Assay methods and compositions for detecting and evaluating the intracellular transduction of an extracellular signal |
| 05/26/1993 | EP0542822A1 Viral (hiv) growth inhibition |
| 05/26/1993 | EP0542770A1 Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| 05/26/1993 | EP0542756A1 Method of introducing a peptide into the cytosol |
| 05/26/1993 | EP0542753A1 Epitopes of the pre-s region of hepatitis b virus surface antigen |
| 05/26/1993 | EP0527802A4 Ligand for the neu gene product |
| 05/26/1993 | EP0513150A4 New method for treating immunodeficiency or neutropenia |
| 05/26/1993 | EP0373218B1 Kidney growth accelerator and process for its preparation |
| 05/26/1993 | EP0167575B1 Cardiodilatine, a new peptide hormone and production process thereof |
| 05/26/1993 | CN1072415A Cyclic vasoactive peptides |
| 05/26/1993 | CN1020924C Production of pluripotent granule cell colony stimulating factor |
| 05/26/1993 | CN1020857C Peptides corresponding to antigenic and immunogenic determinants of major nentralizing proteins of rotaviruses |
| 05/26/1993 | CA2100883A1 Immunoassay using synthetic htlv-ii peptides |
| 05/25/1993 | US5214133 SCL: a hematopoietic growth and differentiation factor |
| 05/25/1993 | US5214132 Polypeptide derivatives of human granulocyte colony stimulating factor |
| 05/25/1993 | US5214033 Factor VIII coagulant polypeptides |
| 05/25/1993 | US5214031 Prophylaxis and treatment of alzheimer's disease |
| 05/25/1993 | US5214030 Urogenital disorders |
| 05/25/1993 | US5213980 Fibroblast growth factor gene transformed hybridoma and enhanced production of antibody |
| 05/25/1993 | US5213970 Human monocyte toxin released from human cells |
| 05/25/1993 | CA1318463C Polypeptide compounds having growth hormone releasing activity |
| 05/25/1993 | CA1318462C Synthetic resin |
| 05/25/1993 | CA1318461C Tripeptide derivatives |
| 05/20/1993 | WO1993010147A1 Novel amylin antagonist peptides and uses therefor |
| 05/20/1993 | CA2100743A1 Amylin antagonist peptides and uses therefor |
| 05/19/1993 | EP0542679A1 Novel hybrid transforming growth factors |
| 05/19/1993 | EP0542525A2 Antithrombotic agents |
| 05/19/1993 | EP0542424A1 Oxytocin recepto and DNA coding for the same |
| 05/19/1993 | EP0542314A1 Formation of protein microparticles by antisolvent precipitation |
| 05/19/1993 | EP0542145A1 Oligosaccharides with antigenic determinants from the jelly coat of amphibian eggs |
| 05/19/1993 | EP0542019A1 8-Hydroxy-2H-dibenz(b,f) azepin-2 one dyes |
| 05/19/1993 | EP0541920A1 Interleukin-1 inhibitors |
| 05/19/1993 | EP0541822A1 Novel calcitonin, and production and use thereof |
| 05/19/1993 | EP0541753A1 NOVEL HYBRID, SOLUBLE AND UNCLEAVED gp160 VARIANT. |
| 05/19/1993 | EP0541726A1 Growth factor compositions, preparation and use |
| 05/19/1993 | EP0541721A1 Expression of human cmv glycoprotein-h using the baculovirus-insect cell expression system |
| 05/19/1993 | EP0541719A1 New carbohydrate-based anti-inflammatory agents |
| 05/19/1993 | EP0541716A1 Novel methods and compositions for treatment of angiogenic diseases |
| 05/19/1993 | EP0541704A1 ASSAY, METHODS AND PRODUCTS BASED ON $i(n) K?+ CHANNEL EXPRESSION |
| 05/19/1993 | EP0541701A1 INTERLEUKIN-4 AND INTERLEUKIN-1$g(b) SYNERGISTICALLY INDUCE VCAM-1 |
| 05/19/1993 | EP0541694A1 Method for treating immune system dysfunctions |
| 05/19/1993 | EP0541692A1 Herpes simplex virus vp16 vaccines |
| 05/19/1993 | EP0541691A1 Nuclear phosphoproteins for prognosticating lymphoid or epithelial cancers |
| 05/19/1993 | EP0541663A1 Peptides and pharmaceutical compositions having glycoprotein hormone agonistic or antagonistic activity |
| 05/19/1993 | EP0541645A1 Method of purifying cytokeratin 20, and the use of cytokeratin 20 to produce antibodies |
| 05/19/1993 | EP0541629A1 CLONING AND EXPRESSION OF A RHOPTRY ASSOCIATED PROTEIN OF $i(P.FALCIPARUM) |
| 05/19/1993 | EP0422072B1 Method of selecting for recombinant pox viruses |
| 05/19/1993 | EP0390821B1 Process for extracting pure fractions of lactoperoxidase and lactoferrin from milk serum |
| 05/19/1993 | EP0343186B1 MOLECULES COMPRISING AT LEAST ONE PEPTIDIC SEQUENCE CARRYING ONE OR A PLURALITY OF EPITOPES CHARACTERIZING A PROTEIN PRODUCED BY $i(P. FALCIPARUM) IN HEPATOCYTES AND COMPOSITIONS CONTAINING THEM |
| 05/19/1993 | EP0179075B1 Virus risk-reduced hemoglobin and method for making same |
| 05/19/1993 | DE4137333A1 Therapeutische mittel, die antagonisten oder partielle agonisten des humanen interleukin 4 sind oder diese enthalten, hil-4-mutantenproteine sowie vefahren zu deren herstellung Therapeutic agents which are antagonists or partial agonists of human interleukin 4 are or contain hIL-4 mutant proteins as well as for their preparation vefahren |
| 05/19/1993 | CN1020752C Vaccines and immunoassays for acquired immune deficiency syndrome |
| 05/19/1993 | CN1020733C Process for preparing covalent conjunct agent of bacterial polysaccharide and immunogen protein |
| 05/18/1993 | US5212297 cDNA clones encoding chicken egg white cystatin |
| 05/18/1993 | US5212290 Monoclonal and polyclonal antibodies |
| 05/18/1993 | US5212286 Atrial natriuretic/vasodilator peptide compounds |
| 05/18/1993 | US5212235 Hydrophobically modified proteins |
| 05/18/1993 | US5212157 Tetrapeptides as inhibitors of HIV |
| 05/18/1993 | US5212091 Method of producing tissue factor pathway inhibitor |
| 05/18/1993 | US5212085 Monoclonal antibodies |
| 05/18/1993 | US5212083 Sequence for stabilizing proteins in bacteria |
| 05/18/1993 | US5212074 Genetic material encoding new insulin-like growth factor binding protein igfbp-6 |
| 05/18/1993 | US5212073 Genetic engineering |
| 05/18/1993 | US5212072 Genetic engineering and DNA sequences |
| 05/18/1993 | US5212071 Nucleic acids encoding a human C3b/C4b receptor (CR1) |
| 05/18/1993 | US5212058 Nucleic acid encoding ubiquitin-specific proteases |
| 05/18/1993 | US5211946 Bacillus thuringiensis isolates for controlling acarides |
| 05/18/1993 | US5211945 Compositions and methods for modulating the effect of tnf and il-1 |
| 05/18/1993 | US5211937 Method of determining a site of inflammation utilizing elam-1 ligands |
| 05/18/1993 | US5211936 Endothelial leukocyte adhesion molecule |
| 05/18/1993 | US5211657 Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides |
| 05/18/1993 | CA1317899C Stabilization of antibodies |
| 05/18/1993 | CA1317878C Method and therapeutic compositions for the treatment of bleeding disorders |
| 05/13/1993 | WO1993009437A2 Nuclear matrix protein fluid assay |
| 05/13/1993 | WO1993009436A1 A method for detecting a differentiation marker in normal and carcinoma cells and in biological samples and body fluid |
| 05/13/1993 | WO1993009251A1 NUCLEOTIDE SEQUENCES HYBRIDIZING SPECIFICALLY WITH BACTERIAL STRAINS OF THE COMPLEX $i(MYCOBACTERIUM AVIUM-INTRACELLULARE) |
| 05/13/1993 | WO1993009238A1 Feline leukemia virus vaccines |
| 05/13/1993 | WO1993009237A1 Improved supersweet corn |
| 05/13/1993 | WO1993009236A1 Myogenic vector systems |
| 05/13/1993 | WO1993009235A2 Ubiquitin-specific proteases |